Glutathione delivery system

Details Glutathione delivery system Glutathione delivery system

1986-01-10

1987-12-01

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, A61K 3702, C07K 508

Patent

active

047104899

ABSTRACT:
Substantially pure alkyl monoesters of glutathione, the ester being of the glycine carboxylic acid, and use thereof to increase cellular levels of glutathione.

REFERENCES:
patent: 2250553 (1941-07-01), Ruskin
patent: 2376186 (1945-05-01), Rapkine
patent: 2702799 (1955-02-01), Laufer et al.
patent: 2711989 (1955-06-01), Laufer et al.
patent: 2900375 (1959-08-01), Amiard et al.
patent: 2938023 (1960-05-01), Weygand et al.
Science; 220, (1983), 472-477.
Puri, et al; Proc. Natl. Acad. Sci. USA; vol. 80, pp. 5258-5260, Sep. 1983.
Wellner, et al; Proc. Natl. Acad. Sci. USA; vol. 81, pp. 4732-4735, Aug. 1984.
Anderson, et al; Archives of Biochemistry and Biophysics; vol. 239, No. 2, Jun., pp. 538-548, 1985.

Affiliated with

Also associated with

Rating

Glutathione delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glutathione delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutathione delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1931510